Uniquely Similar

Biologics are unique and complex molecules and biosimilars are highly similar to the reference biologic.1 Teva has a legacy of value-based generics and branded products. Now Teva is also focusing on biosimilars and educating on the science behind these medicines.

Learn More Below

Biosimilars 101

Understanding Biosimilars

FDA Approval Process

How Biosimilars Get Approved

Biosimilars 101 Brochure


Expanding Treatment Options

Reference: 1. US Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Scientific Considerations in Demonstrating Biosimilarity to a Reference Product. Guidance for Industry. April 2015. https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm291128.pdf. Accessed June 25, 2018.